Sinovac aims for 600 million dose capacity for COVID vaccine
|
December 7, 2020 3:09 AM
TAIPEI, Taiwan (AP) — Chinese vaccine company Sinovac announced Monday that it is planning to complete a new facility to double its annual vaccine production capacity to 600 million doses by the end of the year, while also securing a $500 million investment in a boost to its COVID-19 vaccine development efforts.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
